Diovan Generics Developed as AGs, “No Comment” on December Listing: Sandoz

Sandoz K.K. acknowledged on August 19 that its recently approved generics of Novartis Pharma’s angiotensin receptor blocker Diovan (valsartan) were developed as authorized generics (AGs) based on the patent license granted by Novartis. Sandoz, a generic arm of the Novartis...read more